Comparative Assessment of the Properties of Orthopoxviral Soluble Receptors for Tumor Necrosis Factor

Doklady Biochemistry and Biophysics

Volumn 390, Issue 1-6, 2003, Pages 160-164

  Gileva, I P ^a   Ryazankin, I A ^a   Maksyutov, Z A ^a   Totmenin, A V ^a   Lebedev, L R ^a   Nesterov, A E ^a   Ageenko, V A ^a   Shchelkunov, S N ^a   Sandakhchiev, L S ^a  

^a State Research Center for Virology and Biotechnology Vector rdquo   (Russian Federation)

Author keywords

Comparative Assessment; Soluble Receptor; Tumor Necrosis

Indexed keywords

RECOMBINANT PROTEIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

AMINO ACID SEQUENCE; ANIMAL; ARTICLE; CELL CULTURE; CELL SURVIVAL; COMPARATIVE STUDY; DRUG EFFECT; ESCHERICHIA COLI; FIBROBLAST; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM; METHODOLOGY; MOLECULAR GENETICS; MOUSE; ORTHOPOXVIRUS; PATHOGENICITY; SEQUENCE ALIGNMENT; SPECIES DIFFERENCE; VIRUS GENE;

AMINO ACID SEQUENCE; ANIMALS; CELL SURVIVAL; CELLS, CULTURED; ESCHERICHIA COLI; FIBROBLASTS; GENE EXPRESSION REGULATION, VIRAL; GENES, VIRAL; HUMANS; MICE; MOLECULAR SEQUENCE DATA; ORTHOPOXVIRUS; RECEPTORS, TUMOR NECROSIS FACTOR; RECOMBINANT PROTEINS; SEQUENCE ALIGNMENT; SPECIES SPECIFICITY; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA;

MLCS; MLOWN;

EID: 0141922831     PISSN: 16076729     EISSN: 16083091     Source Type: Journal    
DOI: 10.1023/A:1024468424942     Document Type: Article

References (15)

1. Shchelkunov, S.N., Totmenin, A.V., Safronov, P.F., et al., Virology, 2002, vol. 297, pp. 172-194.
2. Eigler, A., Sinha, B., Hartman, G., and Endres, S., Immunol. Today, 1997, vol. 17, pp. 487-492.
3. Smith, C.A., Davis, T., Anderson, D., et al., Science, 1990, vol. 248, pp. 1019-1023.
4. Smith, C.A., Davis, T., Wignall, J.M., et al., Biochem. Biophys. Res. Commun., 1991, vol. 176, pp. 335-342.
5. Upton, C., Macen, J.L., Schreiber, M., and McFadden, G., Virology, 1991, vol. 184, pp. 370-382.
6. Saraiva, M. and Alcami, A., J. Virol., 2001, vol. 75, pp. 226-233.
7. Shchelkunov, S.N., Marennikova, S.S., Totmenin, A.V., et al., Dokl. Akad. Nauk, 1991, vol. 321, no. 2, pp. 402-406.
8. Shchelkunov, S.N., Safronov, P.F., Totmenin, A.V., et al., Virology, 1998, vol. 243, pp. 432-460.
9. Shchelkunov, S.N., Totmenin, A.V., Babkin, I.V., et al., FEBS Lett., 2001, vol. 509, pp. 66-70.
10. Luchov, V.A., Lee, S.C., Barry, G.F., and Olins, P.O., J. Virol., 1993, vol. 67, pp. 4566-4579.
11. Flick, A.D. and Gifford, G.E., J. Immunol., 1984, vol. 68, p. 167.
12. Lebedev, L.R., Ryazankin, I.A., Sizov, A.A., et al., Biotechnologiya, 2001, no. 6, pp. 14-18.
13. Hall, T.A., Nucl. Acid Symp. Ser., 1999, vol. 41, pp. 95-98.
14. Laemmli, U., Nature, 1970, vol. 227, pp. 680-685.
15. Lebedev, L.R., Zernov, Yu.P., Andreeva, I.S., et al., Biotechnologiya, 1995, no. 12, pp. 19-24.